Join to view full profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-4673
Fax+1 214-645-2615
Dr. Maher is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
McGill University Faculty of MedicineClass of 1993
Certifications & Licensure
TX State Medical License 2006 - 2026
MA State Medical License 1997 - 2007
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas Start of enrollment: 2011 Apr 01
- An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors Start of enrollment: 2009 Aug 28
Publications & Presentations
PubMed
- Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric Response.Luiza Giuliani Schmitt, Michael Dohopolski, Jill de Vis, Thomaz Rodrigues Mostardeiro, Lucas Pari Mitre
International Journal of Radiation Oncology, Biology, Physics. 2026-05-01 - 1 citationsTE optimization for J-difference editing of 2-hydroxyglutarate at 3T.Kimberly L Chan, Rutul Hapani, Elizabeth A Maher, Toral R Patel, Anke Henning
Magnetic Resonance in Medicine. 2025-10-01 - 2 citationsComparative Outcomes of Standard Radiation Therapy and 5-Fraction Adaptive Stereotactic Radiation Therapy in Newly Diagnosed Glioblastoma: A Propensity Score-Matched A...Michael Dohopolski, Luiza Giuliani Schmitt, Jill de Vis, Thomaz Rodrigues Mostardeiro, Soummitra Anand
Advances in Radiation Oncology. 2025-08-01
Press Mentions
New Frontiers in Neuroscience: 10 Years of Progress at UTSW’s O’Donnell Brain InstituteNovember 7th, 2025- Time in a Bottle: How UTSW Paved the Way for a Breakthrough Brain Cancer DrugJuly 1st, 2025
New Test Uncovers Metabolic Vulnerabilities in Kidney CancerAugust 29th, 2018
Grant Support
- Defining The Metabolic Phenotype Of Low Grade Gliomas In VivoNational Cancer Institute2012
- Glioma Metabolism In Patients In VivoNational Center For Research Resources2011
- Genotype And Metabolic Phenotype In GlioblastomaNational Center For Research Resources2010
- Genotype And Metabolic Phenotype In GlioblastomaNational Institute Of Neurological Disorders And Stroke2009–2010
- Metabolism In Human GliomasNational Center For Research Resources2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
